Claim Missing Document
Check
Articles

Found 2 Documents
Search

Analisis Rantai Pasok Stok Obat HIV ARV dengan Metode Double Exponential Smooting Hapsari, Nabilla Windy; Fanani, Aris; Wardani, Susilo Ari; Utami, Wika Dianita
Techno.Com Vol. 23 No. 3 (2024): Agustus 2024
Publisher : LPPM Universitas Dian Nuswantoro

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62411/tc.v23i3.10866

Abstract

Human Immunodeficiency Virus (HIV) merupakan virus yang dapat memicu kerusakan pada sistem kekebalan tubuh manusia, menyebabkan infeksi pada orang yang terkena serta dapat mengurangi sistem kekebalan tubuh dan jika tidak segera disembuhkan akan terjangkit penyakit lain yang disebut dengan Acquired Immuno Deficiency Syndrom (AIDS). Kebutuhan obat ARV bagi ODHA mempengaruhi kebutuhan stok obat yang harus dipasok pemerintah ke Kabupaten/Kota. Dinas Kesehatan Provinsi bertanggung jawab atas perencanaan kebutuhan obat dari pemerintah Kabupaten/Kota, serta penerimaan permintaan obat, penyimpanan, pendistribusian, pencatatan dan pelaporan mutasi obat. Tujuan dari penelitian ini ialah untuk memahami bagaimana rangkaian proses pada supplier, dan penyimpanan obat agar obat tidak mengalami kekosongan atau kelebihan stok dengan menganalisis Rantai Pasok dan melakukan peramalan pada metode Double Exponential Smoothing yang didapatkan hasil presentase error terkecil pada obat Tenofovir dengan nilai MAPE 14,7%.   Kata kunci: Stok obat, HIV ARV, Rantai pasok, Double Exponential Smoothing
Streamlining Oral Antidiabetic Prescribing Through Clinical Pathway Implementation Wardani, Susilo Ari
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 15, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.98056

Abstract

Background: Diabetes mellitus (DM) is a disease that falls into the high-volume, high-risk, and high-cost categories. A concordance of oral anti-diabetic drug prescribing with the clinical pathway (Pedoman Praktik Klinis, PPK) will ensure drug availability for patients in the universal coverage era.Objectives: This study aimed to analyze the quantity and quality of antidiabetic drug use before and after PPK implementation, including concordance with the national formulary and PPK.Methods: This cross-sectional study analyzes oral antidiabetic drug use for inpatient DM (ICD-10 E11) at Sumberglagah Regional Hospital, Mojokerto, East Java Province, Indonesia. Data were collected retrospectively from medical records and the pharmacy database. Drug utilization was presented in Defined Daily Dose per 100 bed-days descriptively.Results: The quantity of inpatient DM drug use was 189.17 DDD/100 bed-days and 249.42 DDD/100 bed-days, before and after PPK implementation. The types of DM drugs that were included in the 90% DU category, before and after PPK implementation, were Insulin Aspart, Insulin Glargine, Glimepiride tablets, and Insulin Glulisine. The quality of DM drug use was 100% following the National Formulary 2022 and the PPK.Conclusion: The oral anti-diabetic drugs in the 90% drug cumulative have great attention in the procurement to raise the financial efficiency. The DDD/100 bed-days of anti-diabetic and the number of items of anti-diabetic drugs are increasing, therefore necessitates proactive strategies to manage potential cost escalation for payers, i.e., The Government of Republic Indonesia.